Google Broadens Diabetes Reach With Dexcom Partnership
This article was originally published in Clinica
Executive Summary
DexCom Inc. is partnering with Google Inc. to develop smaller and cheaper continuous glucose meters (CGM) that would broaden their target market from a current focus on type 1 diabetes patients to the broader population. The partnership also may include using Google's cloud servers to collect and analyze glucose-meter data from patients to improve outcomes and reduce healthcare costs.
You may also be interested in...
New GSK-Verily JV Aims For Smart, 'Grain Of Rice' Neuromod Tech
Galvani Bioelectronics, the new joint venture between Google’s health-care spinoff Verily and drug giant GSK, will develop a new generation of "bioelectronic medicines" – neuromodulating therapies to treat a wide range of chronic diseases. Brian Otis, CTO of Verily, tells Medtech Insight how the devices that will come out of Galvani differ from existing neuromodulation technologies.
‘Aspire To Abide By’ Advertising Laws Crucial For Direct Seller’s Defense Against FTC Complaint
In other finding at odds with previous court decisions, federal judge says direct seller Neora doesn’t have an “agency relationship” to its independent sales representatives and isn’t responsible for ad claims they post.
Direct Seller’s Data Counters FTC’s Pyramid Scheme Complaint Based On ‘Assumption’ About Sales
Ruling in Texas federal court on FTC complaint against Neora could serve as instructions for agency on how not to prosecute pyramid scheme allegations and for direct sellers about operating businesses so regulators find no hint of sales associates’ compensation plans based more on recruiting additional participants than on selling products.